Insider Trading & Ownership of OrbiMed Capital GP VI LLC

Location
New York, NY
Summary
The estimated value of insider holdings of OrbiMed Capital GP VI LLC is at least $5,123,938 dollars as of 23 Apr 2026. OrbiMed Capital GP VI LLC is the Director, 10%+ Owner of Prelude Therapeutics Inc and owns shares of Prelude Therapeutics Inc (PRLD) stock worth about $5M. OrbiMed Capital GP VI LLC is the Director of ImageneBio, Inc. and owns shares of ImageneBio, Inc. (IMA) stock worth about $123.9K.
Signature
Carl L. Gordon
All Insider Reports
All Insider Reports

Follow Filing Activity

Follow OrbiMed Capital GP VI LLC and return when a new Insider Trading filing changes the record on this page.

This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean.

Quick Takeaways

  • OrbiMed Capital GP VI LLC has 3 issuer positions tracked on this page.
  • Estimated disclosed ownership value: $5,123,938.
  • Recent insider filing activity is available below.

What Changed

  • Largest disclosed position: Prelude Therapeutics Inc ($4,999,999).
  • Past-year value change for that position: +$12,499,999.

Why This Matters

  • This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
  • You can cross-check role, issuer, and filing chronology directly against the SEC source.

Source Evidence

Filed on Form 4

Insider ownership context is sourced from SEC Forms 3, 4, and 5.

See Original Filing

Ownership of OrbiMed Capital GP VI LLC

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
PRLD Prelude Therapeutics Inc Director, 10%+ Owner $4,999,999 +$12,499,999 +250% 21 Apr 2026
IMA ImageneBio, Inc. Director $123,939 14 Apr 2026
ACET Adicet Bio, Inc. 10%+ Owner $0 -$674,847 -100% 07 Apr 2026

Insider Transactions Reported by OrbiMed Capital GP VI LLC:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .